Pentwater Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Pentwater Capital Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-300,000	Closed	-$13M	–	162
2015 Q3	$13M	Buy	300,000 +200,000	+200%	+$8.44M	0.11%	73
2015 Q2	$4.23M	Buy	+100,000	New	+$4.22M	0.02%	124

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Pentwater Capital Management's WX Position: Q4 2015 in Review

Pentwater Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 300,000 shares — an estimated $13M sold.

Pentwater Capital Management first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $13M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Pentwater Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Pentwater Capital Management sold 300,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $13M.
Pentwater Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
Pentwater Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $13M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Pentwater Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.